Premier Alternatives

Formation Bio

Drug Discovery · New York, NY · Founded 2013 · Privately Held (backing)

Developer of a biotech investment and development platform intended to accelerate drug development. Formation Bio is based in New York, NY and was founded in 2013. Its last known valuation is $1.7 billion. It has raised $619 million across 1 recorded round; the latest was a $160 million Series C in Sep 2021.

Last price · $/share
—
Implied valuation
$1.7B
Total raised
$618.8M
Last round
Later Stage VC (Series C)
Sep 2021

Formation Bio key facts

  • Developer of a biotech investment and development platform intended to accelerate drug development.
  • Formation Bio’s last known valuation is $1.7B.
  • It has raised $618.8M across 1 recorded rounds; the latest was Later Stage VC (Series C) ($159.5M) in Sep 2021.
  • Notable investors include Andreessen Horowitz, Sequoia Capital, Spark Capital, SV Angel, Felicis — 26 tracked in total.
  • Status: Privately Held (backing).
Free account
More of Formation Bio with a free account
  • ·The complete investor list: 26 names
  • ·Watch Formation Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Formation Bio funding rounds

1 rounds
Sep 2021Later Stage VC (Series C)$159.5M▮
Full funding history →

Formation Bio valuation

Formation Bio's last known valuation is $1.7 billion. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Formation Bio raised?

Formation Bio has raised $619 million in total; 1 of its rounds is on record. The largest on record was a $160 million Series C in Sep 2021.

Formation Bio investors

26 investors are on record for Formation Bio, including Andreessen Horowitz, Sequoia Capital, Spark Capital and SV Angel. By type, the record holds 14 venture capital firms and 1 asset manager. The Series C in Sep 2021 drew 15 investors.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Encoded Therapeutics ($1.8 billion), Areteia Therapeutics ($1.3 billion) and Neurona Therapeutics ($1.1 billion).

About Formation Bio

Developer of a biotech investment and development platform intended to accelerate drug development. The company's platform utilizes AI-driven technologies, customized workflow enhancements, strategic acquisition of clinical-stage assets, adaptable licensing structures, and integrated expert teams, enabling pharma partners and research institutions to advance treatments more efficiently while reducing cost, time, and development risk.

Industry
Drug Discovery
Sector
Healthcare
HQ
New York, NY, United States
Founded
2013
Employees
180
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$1.7B

Formation Bio’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.